Ensuring Markets for New Drugs and Vaccines

May 26, 2005

The International Task Force on Global Public Goods has received the paper it commissioned from Ron Ridker, which looks at the options for advance market commitments to increase incentives for the development of new drugs and vaccines.The paper concludes that an advance market commitment could be effective both for late stage and early stage products, and makes recommendations about how it might be taken forward by the international community.You can see the paper here.


CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.